Could weight loss drugs fix UK’s unemployment problem?
Al Jazeera
US pharmaceuticals group Eli Lilly is to conduct trials of its weight-loss drugs Mounjaro and Zepbound in the UK.
The United Kingdom will study whether the use of weight loss drugs could get people back to work.
UK Health Minister Wes Streeting announced last month that US drug manufacturer Eli Lilly will begin a five-year trial in Greater Manchester to test if the company’s weight loss drug could curb the UK’s unemployment crisis.
The announcement came a day after UK Prime Minister Keir Starmer hosted a summit to encourage investment in the UK, which was attended by Eli Lilly.
But what have weight-loss drugs got to do with unemployment and how will this work?
On October 14, Starmer hosted a summit to encourage investment in the UK. Attendees included David Ricks, the chair of US pharmaceutical giant Eli Lilly, who announced a 279-million-pound ($365.4m) investment in the UK. Further details about how this money would be spent have not been revealed.
